Annual CFO:
-$116.64M-$37.15M(-46.73%)Summary
- As of today, GPCR annual cash from operations is -$116.64 million, with the most recent change of -$37.15 million (-46.73%) on December 31, 2024.
- During the last 3 years, GPCR annual cash from operations has fallen by -$84.48 million (-262.67%).
- GPCR annual cash from operations is now -716.61% below its all-time high of -$14.28 million, reached on December 1, 2020.
Performance
GPCR Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$51.05M+$3.70M(+6.76%)Summary
- As of today, GPCR quarterly cash from operations is -$51.05 million, with the most recent change of +$3.70 million (+6.76%) on September 30, 2025.
- Over the past year, GPCR quarterly cash from operations has dropped by -$31.18 million (-156.93%).
- GPCR quarterly cash from operations is now -413.39% below its all-time high of -$9.94 million, reached on June 1, 2022.
Performance
GPCR Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$194.53M-$31.18M(-19.09%)Summary
- As of today, GPCR TTM cash from operations is -$194.53 million, with the most recent change of -$31.18 million (-19.09%) on September 30, 2025.
- Over the past year, GPCR TTM cash from operations has dropped by -$92.36 million (-90.40%).
- GPCR TTM cash from operations is now -1344.98% below its all-time high of -$13.46 million, reached on March 1, 2022.
Performance
GPCR TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
GPCR Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -46.7% | -156.9% | -90.4% |
| 3Y3 Years | -262.7% | - | - |
| 5Y5 Years | -716.6% | - | - |
GPCR Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -262.7% | at low | -413.4% | +6.8% | -731.1% | at low |
| 5Y | 5-Year | -716.6% | at low | -413.4% | +6.8% | -1345.0% | at low |
| All-Time | All-Time | -716.6% | at low | -413.4% | +6.8% | -1345.0% | at low |
GPCR Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$51.05M(+6.8%) | -$194.53M(-19.1%) |
| Jun 2025 | - | -$54.75M(-4.7%) | -$163.35M(-21.0%) |
| Mar 2025 | - | -$52.30M(-43.5%) | -$134.97M(-15.7%) |
| Dec 2024 | -$116.64M(-46.7%) | -$36.44M(-83.4%) | -$116.69M(-14.2%) |
| Sep 2024 | - | -$19.87M(+24.7%) | -$102.17M(+0.8%) |
| Jun 2024 | - | -$26.37M(+22.5%) | -$103.02M(-10.5%) |
| Mar 2024 | - | -$34.02M(-55.3%) | -$93.27M(-17.4%) |
| Dec 2023 | -$79.49M | -$21.91M(-5.7%) | -$79.42M(-38.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$20.72M(-24.7%) | -$57.51M(-56.3%) |
| Jun 2023 | - | -$16.61M(+17.7%) | -$36.79M(-22.1%) |
| Mar 2023 | - | -$20.18M(-102.9%) | -$30.12M(-28.7%) |
| Dec 2022 | -$46.12M(-43.4%) | - | - |
| Jun 2022 | - | -$9.94M(+26.1%) | -$23.41M(-73.9%) |
| Mar 2022 | - | -$13.46M | -$13.46M |
| Dec 2021 | -$32.16M(-125.2%) | - | - |
| Dec 2020 | -$14.28M | - | - |
FAQ
- What is Structure Therapeutics Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Structure Therapeutics Inc.?
- What is Structure Therapeutics Inc. annual cash from operations year-on-year change?
- What is Structure Therapeutics Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Structure Therapeutics Inc.?
- What is Structure Therapeutics Inc. quarterly cash from operations year-on-year change?
- What is Structure Therapeutics Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Structure Therapeutics Inc.?
- What is Structure Therapeutics Inc. TTM cash from operations year-on-year change?
What is Structure Therapeutics Inc. annual cash from operations?
The current annual cash from operations of GPCR is -$116.64M
What is the all-time high annual cash from operations for Structure Therapeutics Inc.?
Structure Therapeutics Inc. all-time high annual cash from operations is -$14.28M
What is Structure Therapeutics Inc. annual cash from operations year-on-year change?
Over the past year, GPCR annual cash from operations has changed by -$37.15M (-46.73%)
What is Structure Therapeutics Inc. quarterly cash from operations?
The current quarterly cash from operations of GPCR is -$51.05M
What is the all-time high quarterly cash from operations for Structure Therapeutics Inc.?
Structure Therapeutics Inc. all-time high quarterly cash from operations is -$9.94M
What is Structure Therapeutics Inc. quarterly cash from operations year-on-year change?
Over the past year, GPCR quarterly cash from operations has changed by -$31.18M (-156.93%)
What is Structure Therapeutics Inc. TTM cash from operations?
The current TTM cash from operations of GPCR is -$194.53M
What is the all-time high TTM cash from operations for Structure Therapeutics Inc.?
Structure Therapeutics Inc. all-time high TTM cash from operations is -$13.46M
What is Structure Therapeutics Inc. TTM cash from operations year-on-year change?
Over the past year, GPCR TTM cash from operations has changed by -$92.36M (-90.40%)